This site focuses on the inflammatory cytokine, IL-17A, its key role in the pathogenesis of psoriasis and the IL-17 pathway itself as a target for therapeutic intervention.
Highlights include a series of Interactive Publications on Secukinamab – a new feature for viewing current papers.
A series of educational slide decks covering disease pathophysiology, assessment and treatment are available to view from this section of the IL-17A in Psoriasis Knowledge Centre.
Watch this video to learn how antibodies directed towards IL-17A, a key inflammatory cytokine in psoriasis, target the inflammatory process.
Watch recent sponsored satellite symposia from various world leading events, such as EADV, WPPAC and PGC.
Here you can access several journal articles related to general psoriasis, the IL-17 pathways and its clinical data.